Immune cell study for severe infection patients in the ICU
Part of Infections clinical trials.
This study wants to learn how your immune system reacts to a serious infection (like sepsis) in the ICU. By looking at your immune cells, doctors hope to better predict your recovery and find the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are currently in the intensive care unit (ICU).
- You have a serious infection (like sepsis) diagnosed by your doctor.
- You or a family member agrees to be part of this study.
- You do not have a history of blood cancer or active cancer needing chemotherapy.
- You are not pregnant or breastfeeding.
- You are not taking long-term medications that weaken your immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This trial looks at natural molecules that help the body resolve severe infections. Researchers want to understand how these molecules affect recovery and identify patient types that respond best. It may help improve treatment for people in the ICU with serious infections.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.